Chieh-Feng Lee1, Tai-An Chen. 1. Department of Otolaryngology, Chang Gung Memorial Hospital, Keelung, Taiwan 204, R.O.C. lcf5211@cgmh.org.tw
Abstract
BACKGROUND: In this article, microdebrider-assisted modification of endoscopic inferior turbinoplasty is described. It has the advantage of superior visualization during elevation of the mucosal flap and allows precise tailoring of the resection to the needs of patients. METHODS: From November 2001 to December 2002, 29 patients with chronic hypertrophic rhinitis treated with power endoscopic inferior turbinoplasty were available for follow-up examinations. Questionnaires and rhinomanometric studies were performed for subjective and objective evaluations. These patients were followed up for an average of 15.3 months after the operation. RESULTS: The overall improvement in nasal obstruction was 91% in our study. Twenty-two patients received rhinomanometric studies 1 week preoperatively and 2 months postoperatively. The average nasal airflow was increased by 187 ml/min. In addition, complete relief of headaches was achieved. But the remission rates of persistent rhinorrhea and post-nasal dripping were less significant, at about 58% and 54%, respectively. Atrophic change and permanent synechiae had not yet been observed. CONCLUSIONS: Power endoscopic turbintoplasty is a safe, simple, and effective method for the treatment of chronic hypertrophic rhinitis. It is especially handy in adjunct to endoscopic septoplasty or sinosurgery, and appears to provide a surgical choice of a minimally invasive technique. However, further study with a prospective design is needed to strengthen the evidence.
BACKGROUND: In this article, microdebrider-assisted modification of endoscopic inferior turbinoplasty is described. It has the advantage of superior visualization during elevation of the mucosal flap and allows precise tailoring of the resection to the needs of patients. METHODS: From November 2001 to December 2002, 29 patients with chronic hypertrophic rhinitis treated with power endoscopic inferior turbinoplasty were available for follow-up examinations. Questionnaires and rhinomanometric studies were performed for subjective and objective evaluations. These patients were followed up for an average of 15.3 months after the operation. RESULTS: The overall improvement in nasal obstruction was 91% in our study. Twenty-two patients received rhinomanometric studies 1 week preoperatively and 2 months postoperatively. The average nasal airflow was increased by 187 ml/min. In addition, complete relief of headaches was achieved. But the remission rates of persistent rhinorrhea and post-nasal dripping were less significant, at about 58% and 54%, respectively. Atrophic change and permanent synechiae had not yet been observed. CONCLUSIONS: Power endoscopic turbintoplasty is a safe, simple, and effective method for the treatment of chronic hypertrophic rhinitis. It is especially handy in adjunct to endoscopic septoplasty or sinosurgery, and appears to provide a surgical choice of a minimally invasive technique. However, further study with a prospective design is needed to strengthen the evidence.